World PulseNow
Newsletter

Moderna boss defends UK in drug-pricing row as he opens £150m Oxfordshire facility

The Guardian•Wednesday, September 24, 2025 at 11:01:20 PM
PositiveFinancial Markets
Moderna boss defends UK in drug-pricing row as he opens £150m Oxfordshire facility
Darius Hughes, the UK head of Moderna, has defended the UK's drug pricing amidst criticism from other pharmaceutical companies, labeling the comments as 'a little harsh.' His remarks came during the opening of a new £150 million vaccine facility in Oxfordshire, highlighting Moderna's commitment to investing in the UK. This facility is significant not only for its economic impact but also for its potential to enhance vaccine production and accessibility, especially in the wake of the pandemic.
— Curated by the World Pulse Now AI Editorial System
Read Original

Was this article worth reading? Share it

Recommended Readings
Moderna stock rises as Brookline reiterates Buy on strong COVID vaccine data
Investing.com2 days ago
Moderna stock rises as Brookline reiterates Buy on strong COVID vaccine data
PositiveFinancial Markets
Moderna's stock has seen a significant rise following Brookline's decision to reiterate a 'Buy' rating based on promising new data regarding its COVID vaccine. This positive endorsement highlights the confidence in Moderna's ongoing efforts to combat the pandemic, which is crucial for both public health and investor sentiment. As the world continues to navigate the challenges posed by COVID-19, strong vaccine performance is vital for recovery and stability in the market.
Read full article
via Investing.com
Moderna stock rises as Brookline reiterates Buy on strong COVID vaccine data
Investing.com2 days ago
Moderna stock rises as Brookline reiterates Buy on strong COVID vaccine data
PositiveFinancial Markets
Moderna's stock has seen a significant rise following Brookline's decision to reiterate a 'Buy' rating based on promising new data regarding its COVID vaccine. This positive endorsement highlights the confidence in Moderna's ongoing efforts to combat the pandemic, which is crucial for both public health and investor sentiment. As the world continues to navigate the challenges posed by COVID-19, strong vaccine performance is vital for recovery and stability in the market.
Read full article
via Investing.com
Latest from Financial Markets
Gas prices are down. Here’s why — and could they drop more soon?
Global News41 minutes ago
Gas prices are down. Here’s why — and could they drop more soon?
PositiveFinancial Markets
Gas prices in Canada are experiencing a significant drop, thanks to seasonal changes and the removal of the consumer carbon price, which is leading to even greater savings for consumers. This is great news for drivers, as it means more money in their pockets during a time when fuel costs can be a burden. With prices heading towards some of the lowest levels of the year, many are hopeful that this trend could continue, making travel and commuting more affordable.
Read full article
via Global News
Baiterek National Holding completes $500 million note offering
Investing.com42 minutes ago
Baiterek National Holding completes $500 million note offering
PositiveFinancial Markets
Baiterek National Holding has successfully completed a $500 million note offering, marking a significant milestone in its financial strategy. This move not only strengthens its capital base but also enhances its ability to support various development projects in Kazakhstan. The successful offering reflects investor confidence in the holding's future prospects and contributes positively to the financial market, showcasing the potential for growth and investment in the region.
Read full article
via Investing.com
DMG Blockchain stock rating assumed by Canaccord with Buy, target raised
Investing.com43 minutes ago
DMG Blockchain stock rating assumed by Canaccord with Buy, target raised
PositiveFinancial Markets
DMG Blockchain has received a positive boost as Canaccord has assumed its stock rating with a 'Buy' recommendation and raised its target price. This is significant as it reflects growing confidence in DMG's potential for growth and profitability, which could attract more investors and positively impact the company's market position.
Read full article
via Investing.com
Rosenblatt initiates Webull stock with Buy rating, $19 price target
Investing.com44 minutes ago
Rosenblatt initiates Webull stock with Buy rating, $19 price target
PositiveFinancial Markets
Rosenblatt has initiated coverage of Webull with a Buy rating and set a price target of $19. This is significant as it reflects confidence in Webull's growth potential and market position, which could attract investors looking for promising opportunities in the stock market.
Read full article
via Investing.com
Barclays upgrades Kodiak Sciences stock rating on promising KSI-101 data
Investing.com44 minutes ago
Barclays upgrades Kodiak Sciences stock rating on promising KSI-101 data
PositiveFinancial Markets
Barclays has upgraded its rating for Kodiak Sciences following promising data on KSI-101, a treatment that shows potential in addressing significant medical needs. This upgrade reflects confidence in the company's future prospects and could attract more investors, highlighting the importance of innovative therapies in the pharmaceutical industry.
Read full article
via Investing.com
B.Riley initiates Blackstone Secured Lending Fund stock with Buy rating
Investing.com44 minutes ago
B.Riley initiates Blackstone Secured Lending Fund stock with Buy rating
PositiveFinancial Markets
B.Riley has initiated coverage of the Blackstone Secured Lending Fund with a Buy rating, signaling strong confidence in the fund's performance. This is significant as it highlights the potential for investors to benefit from the fund's strategies in a challenging market, making it an attractive option for those looking to diversify their portfolios.
Read full article
via Investing.com